Evidence map›Paper›PMID 41220884›Full record

ReviewKorean journal of neurotrauma2025

Intramedullary Neural Stem Cell Transplantation in Spinal Cord Injury: Timing, Targets, and Techniques.

Sunghyun Kwon, Suk Hyung Kang, Myeong Jin Ko, Byung-Jou Lee, Woo-Keun Kwon, Sang Ryong Jeon, Kyung Taek Oh, Subum Lee

Abstract readReview
In one paragraph

Review in Korean journal of neurotrauma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sunghyun KwonDepartment of Neurosurgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
Suk Hyung KangDepartment of Neurosurgery, Kyunghee University Hospital, Kyunghee University College of Medicine, Seoul, Korea.
Myeong Jin KoDepartment of Neurosurgery, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1850-7753
Byung-Jou LeeDepartment of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.ORCID https://orcid.org/0000-0002-4030-3618
Woo-Keun KwonDepartment of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-0432-8620
Sang Ryong JeonDepartment of Neurological Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8340-7978
Kyung Taek OhDepartment of Biotechnology, Korea University College of Life Sciences and Biotechnology, Seoul, Korea.
Subum LeeDepartment of Neurosurgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-4732-8137

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury remains one of the most challenging neurological disorders due to limited intrinsic regeneration. Neural stem cell (NSC) transplantation offers a promising strategy for restoring neural circuitry and functional recovery. Among delivery methods, direct intramedullary transplantation provides the most localized graft placement and has shown encouraging safety and efficacy in early clinical trials. This review summarizes current evidence and technical considerations for intramedullary NSC transplantation. Key factors influencing outcomes include timing after injury, cell source, surgical approach, and host microenvironment. Advances in microsurgical delivery techniques and biomaterial scaffolds have improved graft survival and integration while minimizing procedure-related risks. Clinical data demonstrate that intramedullary NSC transplantation is feasible and generally safe, with early signals of motor improvement. Nevertheless, challenges remain in achieving consistent cell engraftment and long-term functional gains. Future work should focus on refining transplantation parameters, establishing standardized surgical protocols, and conducting multicenter trials with long-term follow-up to confirm clinical efficacy. By integrating current findings, this review provides a concise overview of surgical evolution and translational progress, highlighting intramedullary NSC transplantation as a key frontier in regenerative spinal surgery.

Indexed as

Clinical trialCordotomyNeural stem cellsSpinal cord injurySpinal cord regenerationTechnique

Identifiers

PMID41220884
PMCPMC12599414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.